Keywords: sepracor, eisai, sell, eszopiclone, japan, research-based, pharmaceutical

Sepracor and Eisai to sell eszopiclone in Japan

Article | 06 August 2007

US research-based pharmaceutical company Sepracor has signed an agreement with Japanese drugmaker Eisai that will focus on the commercialization of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing

Related Drugs

Eszopiclone

Lunesta

Go to drug listing